AMERICAN SOCIETY OF HEMATOLOGY

66th ASH Annual Meeting & Exposition

 

December 7-10, 2024 San Diego
Virtual Poster Gallery
By
Text
In




Please scroll to the right or left using the arrows above to find your poster. You can also use the List View and Advanced Search to find your poster.
PosterSessionOnline
   Previous range   ... 4379-4398 | 4399-4418 | 4419-4434 | 4434-4452 | 4453-4471 | ...  Next range
posters found | 4261
Poster no.
Poster/abstract title
Author
Topics
MON-4399 Orelabrutinib in Patients with Indolent Non-Hodgkin Lymphoma (iNHL) Who Are Intolerant to Prior Brut.. Li Wang 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell..
MON-4400 Persistence of Monotypic Plasma Cells after Chemoimmunotherapy in Patients with Waldenstroem Macrogl.. Marzia Varettoni 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell..
MON-4401 Impact of Bone Marrow Evaluation Using Bone Marrow Biopsy, Flow Cytometry, and PET/CT in B-Cell Non-.. José Antonio Sánchez Salas 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell..
MON-4402 Second Primary Malignancies in Marginal Zone Lymphoma Survivors Kriti Ahuja 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell..
MON-4403 Evolution of Treatment Patterns and Sequencing in Mantle Cell Lymphoma (MCL) in Spain and Their Impa.. Ana Marin Niebla 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell..
MON-4404 A Phase II Trial of Loncastuximab Tesirine in Patients with Previously Treated Waldenstroem Macroglo.. Shayna R Sarosiek 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell..
MON-4405 Zilovertamab Vedotin Monotherapy for Patients with Relapsed or Refractory Mantle Cell Lymphoma: Coho.. Ingrid Glimelius 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell..
MON-4406 Real World First-Line Treatment Strategies and Outcomes in TP53 Mutated and Unmutated Mantle Cell Ly.. Jie Wang 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell..
MON-4407 Mosunetuzumab Continues to Demonstrate Clinically Meaningful Outcomes in Patients with Relapsed and/.. Mazyar Shadman 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell..
MON-4408 Preliminary Efficacy and Safety of a Phase 1/2 Study of Acalabrutinib, Venetoclax, and Obinutuzumab .. Austin I. Kim 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell..
MON-4409 Long-Term Follow-up of Bendamustine/Rituximab – Rituximab/Cytarabine (BR/RC) Induction Therapy for P.. Christine Ryan 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell..
MON-4410 Obinutuzumab, Lenalidomide and Venetoclax for the Initial Treatment of Patients with Advanced-Stage .. Chan Y. Cheah 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell..
MON-4411 Odronextamab Monotherapy in Previously Untreated Patients with High-Risk Follicular Lymphoma (FL): R.. Elizabeth Brem 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell..
MON-4412 Long-Term Impact of Dose Interruptions (DIs) of Bruton Tyrosine Kinase Inhibitors (BTKis) on Change .. Judith Trotman 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell..
MON-4413 Importance of Access Inequality and Biological Prognostic Factors in Mantle Cell Lymphoma Outcomes i.. Rony Schaffel 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell..
MON-4414 Mosunetuzumab Plus Polatuzumab Vedotin Induces Early Complete Responses in Previously Untreated High.. David Russler-Germain 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell..
MON-4415 A Phase I/II Study of Tazemetostat Combined with Abbreviated Rituximab/Bendamustine Therapy for High.. Vaishalee P Kenkre 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell..
MON-4416 Practices and Outcomes during a Watch and Wait Approach for Follicular Lymphoma: A Study from the Au.. Joshua Tobin 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell..
MON-4417 Asymptomatic Multicentric Castleman Disease: A Potential Early Stage of Idiopathic Mcd Lu Zhang 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell..
MON-4418 Multicenter Retrospective Cohort Study of 694 Patients with Ocular Adnexal Marginal Zone B-Cell Lymp.. Liang Wang 623. Mantle Cell, Follicular, Waldenstrom´s, and Other Indolent B Cell..
RATE THE POSTER BETWEEN ONE AND FIVE STARS

CANCEL
RATE
Close abstract

Abstract

Thunderstorm-related asthma in patients sensitised to olea europaea pollen: twenty emergency department visits for asthmatic symptoms in one single day Losappio, Laura1; Heffler, Enrico2; Falco, Antonio1; Contento, Francesco1; Cannito, Cosimo1; Rolla, Giovanni2 1"Dimiccoli" Hospital, Emergency Department, Barletta, Italy; 2University of Torino - AO Mauriziano "Umberto I", Allergy and Clinical Immunology, Torino, Italy

Background: Associations between thunderstorm and asthma morbidity have been reported in several countries. Common to all epidemics of thunderstorm-related asthma is a significant increase in atmospheric allergen load during and immediately after a thunderstorm. Sensitization to Alternaria species or to grass and parietaria pollens has been suggested to play a key role in thunderstorm-related asthma. The only reported event of thunderstorm-related asthma in Mediterranean area was attributed to sensitization to parietaria pollen.

Method: here we describe a series of 20 patients who presented to Emergency Department in Barletta (94,000 inhabitants), Puglia (Italy) for sudden and severe asthmatic symptoms between May 27th and 28th 2010 (from15:36 to 5:02), immediately after a violent thunderstorm which occurred following a very hot morning (mean temperature: 29°C). All the patients have been subsequently visited by an allergist and underwent allergological work-up which included skin prick tests and a careful clinical history. Local pollen counts were available.

Result: Between May 10th and June 10th 2010, 86 Emergency Department asthma visits were recorded, 20 of them during the study day. Patients' mean age was 44.25 +/- 18.5 years (range: 9-81), 8/20 females, 2 smokers, 16 with a previous history of known respiratory allergy. Only two patients regularly took anti-asthma drugs. All 20 patients were sensitized to Olea europaea pollen, 7 of whom were monosensitized. Ten patients were sensitized to grass, 7 to parietaria, 5 to compositae, 5 to cypress, 5 to house dust mites, 3 to dog and 1 to cat danders. No patient was sensitized to Alternaria. Mean pollen count was 17 granules/m3 for Olea europaea, 6 granules/m3 for grass pollen.

Conclusion: This is, in our knowledge, the second epidemic of thunderstorm related asthma described in Mediterranean area and the first one in which sensitization to Olea europaea played a key-role. In conclusion, our report indicates that thunderstorm asthma may involve different allergens (not only fungal spores and grass or parietaria pollen) in different geographic areas, depending on the seasonality of thunderstorms and allergenic pollen.

 
Previous     Next           Close poster
DETAILS
DETAILS
VIDEO PRESENTATION